Tacrolimus in refractory polymyositis with interstitial lung disease
- PMID: 10347992
- PMCID: PMC2977932
- DOI: 10.1016/S0140-6736(99)01927-3
Tacrolimus in refractory polymyositis with interstitial lung disease
Figures

References
-
- Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific antibodies define useful homogeneous patient groups. Medicine. 1991;70:360–374. - PubMed
-
- Jaffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med. 1993;94:379–387. - PubMed
-
- Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in PM and DM. Semin Arthritis Rheum. 1988;18:29–37. - PubMed
-
- Yocum DE. Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheumatic Dis Clin N Am. 1996;22:133–153. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical